← All trials
NCT05906511
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2023
- Primary completion
- Apr 30, 2025
- Completion date
- Jul 30, 2025
- First posted
- Jun 18, 2023
- Last posted
- Nov 15, 2023
- Enrollment
- 30
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Yale UniversityLead sponsor
- National Institute on Drug Abuse (NIDA)Collaborator
- Yale UniversityOverall official - principal investigator
- Yale UniversityReponsible party - principal investigator
- Department of Veteran AffairsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.